A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.

Kumar, Poornima; Mediwake, Rapti; Rhead, Camilla

Kumar, Poornima; Mediwake, Rapti; Rhead, Camilla.

Kumar P; Department of Clinical Haematology, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
Mediwake R; Department of Rheumatology and General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
Rhead C; Department of General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.

Br J Hosp Med (Lond) ; 81(5): 1-2, 2020 May 02.

Article in English | MEDLINE | ID: covidwho-427486

Subject(s)

Anticoagulants/administration & dosage; Coronavirus Infections/complications; Pneumonia, Viral/complications; Venous Thromboembolism/etiology; Venous Thromboembolism/prevention & control; Anticoagulants/adverse effects; Betacoronavirus; COVID-19; Drug Administration Schedule; Fondaparinux/administration & dosage; Fondaparinux/adverse effects; Heparin, Low-Molecular-Weight/administration & dosage; Heparin, Low-Molecular-Weight/adverse effects; Humans; Pandemics; Patient Discharge; Risk Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Venous Thromboembolism / Anticoagulants Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Br J Hosp Med (Lond) Journal subject: Hospitals / Medicine Year: 2020 Document Type: Article Affiliation country: Hmed.2020.0210

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google